rapacuronium

Known as: rapacuronium [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Preclinical Safety Pharmacology (PSP) attempts to anticipate adverse drug reactions (ADRs) during early phases of drug discovery… (More)
Is this relevant?
2003
2003
BACKGROUND A safe and effective ultra-short-acting nondepolarizing neuromuscular blocking agent is required to block nicotinic… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2002
2002
UNLABELLED The administration of rapacuronium increases the risk of severe bronchospasm. There have been no studies of pulmonary… (More)
Is this relevant?
2001
2001
The patient was a 10-yr-old girl who was brought to the operating room to undergo appendectomy. Except for 1 week of abdominal… (More)
  • table 1
  • figure 1
Is this relevant?
2000
2000
BACKGROUND A rigorous study of the dose-response relation of rapacuronium has, to our knowledge, yet to be performed. In addition… (More)
Is this relevant?
1999
1999
Background: Delayed elimination kinetics of steroidal neuromuscular blocking agents have been observed in patients with cirrhosis… (More)
Is this relevant?
1999
1999
UNLABELLED Neuromuscular blocking drugs may have variable effects on heart rate (HR) and blood pressure. Rapacuronium is a rapid… (More)
Is this relevant?
1999
1999
BACKGROUND Rapacuronium is a new nondepolarizing muscle relaxant with rapid onset and offset. As part of a study to determine its… (More)
Is this relevant?
1999
1999
BACKGROUND Rapacuronium is a rapid-onset, short-acting neuromuscular relaxant. This multiple-center study determined… (More)
Is this relevant?
1999
1999
UNLABELLED Rapacuronium (Org 9487) is a rapid-onset and short- to intermediate-acting muscle relaxant. Its 3-desacetyl metabolite… (More)
Is this relevant?